ANNE VANLENT - 11 Jun 2025 Form 4 Insider Report for Trevi Therapeutics, Inc. (TRVI)

Role
Director
Signature
/s/ Christopher Galletta, attorney-in-fact
Issuer symbol
TRVI
Transactions as of
11 Jun 2025
Net transactions value
$0
Form type
4
Filing time
13 Jun 2025, 16:00:19 UTC
Previous filing
14 Jun 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
VANLENT ANNE Director C/O TREVI THERAPEUTICS, INC., 195 CHURCH STREET, 16TH FLOOR, NEW HAVEN /s/ Christopher Galletta, attorney-in-fact 13 Jun 2025 0001229243

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TRVI Nonstatutory Stock Option (right to buy) Award $0 +45,000 $0.000000 45,000 11 Jun 2025 Common Stock 45,000 $6.25 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on June 11, 2025. This option is scheduled to fully vest on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the next annual meeting of stockholders of the Issuer held following the date of grant, subject to the recipient's continued service as a director, employee or consultant of the Issuer.